Related Experiment Video
Updated: Feb 27, 2026
09:43
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
3.6K
Current status of lupus nephritis
1Department of Nephrology, Indira Gandhi Medical College (IGMC), Shimla, India.
The Indian Journal of Medical Research
|June 23, 2017
Summary
This review discusses the evolution of lupus nephritis (LN) treatments, highlighting current immunosuppression therapies and the need for novel, safer options. It emphasizes an individualized approach to managing this SLE complication.
Area of Science:
- Nephrology
- Rheumatology
- Immunology
Background:
- Systemic lupus erythematosus (SLE) is a complex autoimmune disease with variable outcomes.
- Lupus nephritis (LN) significantly impacts patient prognosis and quality of life.
- Current immunosuppressive therapies have improved SLE and LN management but have limitations.
Purpose of the Study:
- To review the current evidence and evolution of lupus nephritis treatment strategies.
- To discuss new classification criteria for SLE.
- To provide rationale for specific immunosuppressive regimens in LN management.
Main Methods:
- Comprehensive literature review of immunosuppression in lupus nephritis.
- Analysis of recent advancements in SLE classification.
- Evaluation of therapeutic agents including mycophenolate mofetil, calcineurin inhibitors, and rituximab.
Main Results:
- Established immunosuppression protocols have improved patient outcomes.
- Emerging therapeutic agents show promise but require further investigation.
- Low-dose intravenous cyclophosphamide followed by azathioprine is a potential maintenance strategy.
Conclusions:
- Continued research is essential for developing more targeted and safer LN therapies.
- An individualized and holistic approach to patient care is crucial.
- Updated SLE classification criteria aid in diagnosis and management.
Related Concept Videos
01:24Nephrotic Syndrome III : Nursing Management
398
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
398
01:26Nephrotic Syndrome II : Assessment and Medical Management
279
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
279
01:16Kidney Transplant III: Nursing Management
454
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
454
01:24Nephrotic Syndrome I : Introduction
748
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
748
01:29Acute Kidney Injury III: Clinical Manifestations
1.1K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.1K
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
532
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
532